NanJing Pharmaceutical Company Limited (600713.SS)
CNY 5.2
(-0.38%)
CNY 5.2
(-0.38%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 53.58 Billion CNY | 6.49% |
| 2022 | 50.22 Billion CNY | 11.3% |
| 2021 | 45.12 Billion CNY | 13.33% |
| 2020 | 39.81 Billion CNY | 7.16% |
| 2019 | 37.15 Billion CNY | 18.7% |
| 2018 | 31.3 Billion CNY | 13.94% |
| 2017 | 27.47 Billion CNY | 2.82% |
| 2016 | 26.72 Billion CNY | 7.69% |
| 2015 | 24.81 Billion CNY | 12.4% |
| 2014 | 22.07 Billion CNY | 17.81% |
| 2013 | 18.73 Billion CNY | 3.96% |
| 2012 | 18.02 Billion CNY | 4.96% |
| 2011 | 17.17 Billion CNY | 11.96% |
| 2010 | 15.33 Billion CNY | 9.36% |
| 2009 | 14.02 Billion CNY | 23.07% |
| 2008 | 11.39 Billion CNY | 21.95% |
| 2007 | 9.34 Billion CNY | 36.87% |
| 2006 | 6.82 Billion CNY | 9.6% |
| 2005 | 6.22 Billion CNY | 18.44% |
| 2004 | 5.25 Billion CNY | 24.71% |
| 2003 | 4.21 Billion CNY | 103.87% |
| 2002 | 2.06 Billion CNY | 44.8% |
| 2001 | 1.42 Billion CNY | 7.48% |
| 2000 | 1.32 Billion CNY | 15.96% |
| 1999 | 1.14 Billion CNY | 30.33% |
| 1998 | 879.49 Million CNY | 51.03% |
| 1997 | 582.33 Million CNY | 15.82% |
| 1996 | 502.8 Million CNY | 2.64% |
| 1995 | 489.87 Million CNY | 20.65% |
| 1994 | 406.03 Million CNY | -10.76% |
| 1993 | 454.98 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 13.92 Billion CNY | 7.06% |
| 2024 Q2 | 13.27 Billion CNY | -4.65% |
| 2024 Q3 | 13.67 Billion CNY | 3.21% |
| 2023 Q2 | 13.26 Billion CNY | -5.83% |
| 2023 Q4 | 13 Billion CNY | -1.47% |
| 2023 FY | 53.48 Billion CNY | 6.49% |
| 2023 Q1 | 14.08 Billion CNY | 10.14% |
| 2023 Q3 | 13.2 Billion CNY | -0.43% |
| 2022 Q1 | 11.7 Billion CNY | -0.22% |
| 2022 Q2 | 12.24 Billion CNY | 4.61% |
| 2022 Q3 | 13.49 Billion CNY | 10.25% |
| 2022 Q4 | 12.78 Billion CNY | -5.26% |
| 2022 FY | 50.22 Billion CNY | 11.3% |
| 2021 Q1 | 11.08 Billion CNY | 3.18% |
| 2021 FY | 45.12 Billion CNY | 13.33% |
| 2021 Q2 | 10.81 Billion CNY | -2.46% |
| 2021 Q3 | 11.5 Billion CNY | 6.36% |
| 2021 Q4 | 11.72 Billion CNY | 1.97% |
| 2020 Q4 | 10.74 Billion CNY | -0.54% |
| 2020 FY | 39.81 Billion CNY | 7.16% |
| 2020 Q1 | 8.78 Billion CNY | -7.13% |
| 2020 Q2 | 9.48 Billion CNY | 7.9% |
| 2020 Q3 | 10.8 Billion CNY | 13.9% |
| 2019 Q1 | 8.73 Billion CNY | 0.33% |
| 2019 Q3 | 9.77 Billion CNY | 6.53% |
| 2019 FY | 37.15 Billion CNY | 18.7% |
| 2019 Q4 | 9.46 Billion CNY | -3.21% |
| 2019 Q2 | 9.17 Billion CNY | 5.07% |
| 2018 Q2 | 7.23 Billion CNY | -3.82% |
| 2018 Q3 | 7.82 Billion CNY | 8.13% |
| 2018 FY | 31.3 Billion CNY | 13.94% |
| 2018 Q4 | 8.7 Billion CNY | 11.23% |
| 2018 Q1 | 7.52 Billion CNY | 7.22% |
| 2017 Q3 | 6.96 Billion CNY | 2.21% |
| 2017 Q1 | 6.68 Billion CNY | -4.53% |
| 2017 Q4 | 7.02 Billion CNY | 0.87% |
| 2017 Q2 | 6.8 Billion CNY | 1.9% |
| 2017 FY | 27.47 Billion CNY | 2.82% |
| 2016 Q3 | 6.76 Billion CNY | 5.82% |
| 2016 Q1 | 6.57 Billion CNY | 2.12% |
| 2016 FY | 26.72 Billion CNY | 7.69% |
| 2016 Q4 | 6.99 Billion CNY | 3.54% |
| 2016 Q2 | 6.38 Billion CNY | -2.8% |
| 2015 FY | 24.81 Billion CNY | 12.4% |
| 2015 Q2 | 6.09 Billion CNY | 3.33% |
| 2015 Q4 | 6.43 Billion CNY | 0.72% |
| 2015 Q3 | 6.38 Billion CNY | 4.89% |
| 2015 Q1 | 5.89 Billion CNY | 4.68% |
| 2014 Q3 | 5.7 Billion CNY | 4.05% |
| 2014 Q4 | 5.63 Billion CNY | -1.3% |
| 2014 FY | 22.07 Billion CNY | 17.81% |
| 2014 Q1 | 5.25 Billion CNY | 10.21% |
| 2014 Q2 | 5.48 Billion CNY | 4.42% |
| 2013 Q4 | 4.76 Billion CNY | -0.08% |
| 2013 Q1 | 4.52 Billion CNY | 5.63% |
| 2013 FY | 18.73 Billion CNY | 3.96% |
| 2013 Q3 | 4.76 Billion CNY | 2.03% |
| 2013 Q2 | 4.67 Billion CNY | 3.25% |
| 2012 Q1 | 4.46 Billion CNY | 1.07% |
| 2012 Q2 | 4.6 Billion CNY | 3.29% |
| 2012 Q3 | 4.66 Billion CNY | 1.35% |
| 2012 Q4 | 4.28 Billion CNY | -8.21% |
| 2012 FY | 18.02 Billion CNY | 4.96% |
| 2011 Q4 | 4.41 Billion CNY | -1.12% |
| 2011 Q2 | 4.18 Billion CNY | 1.88% |
| 2011 Q1 | 4.1 Billion CNY | 13.75% |
| 2011 FY | 17.17 Billion CNY | 11.96% |
| 2011 Q3 | 4.46 Billion CNY | 6.63% |
| 2010 Q2 | 4.14 Billion CNY | 11.26% |
| 2010 Q1 | 3.72 Billion CNY | -16.84% |
| 2010 Q4 | 3.61 Billion CNY | -6.39% |
| 2010 FY | 15.33 Billion CNY | 9.36% |
| 2010 Q3 | 3.85 Billion CNY | -6.86% |
| 2009 Q3 | 3.27 Billion CNY | -5.55% |
| 2009 FY | 14.02 Billion CNY | 23.07% |
| 2009 Q4 | 4.47 Billion CNY | 36.7% |
| 2009 Q1 | 2.8 Billion CNY | -13.58% |
| 2009 Q2 | 3.46 Billion CNY | 23.69% |
| 2008 Q2 | 2.84 Billion CNY | 4.2% |
| 2008 FY | 11.39 Billion CNY | 21.95% |
| 2008 Q4 | 3.24 Billion CNY | 25.63% |
| 2008 Q3 | 2.58 Billion CNY | -9.13% |
| 2008 Q1 | 2.72 Billion CNY | 3.85% |
| 2007 Q4 | 2.62 Billion CNY | 23.71% |
| 2007 Q1 | 2.06 Billion CNY | 17.73% |
| 2007 FY | 9.34 Billion CNY | 36.87% |
| 2007 Q2 | 2.52 Billion CNY | 22.05% |
| 2007 Q3 | 2.12 Billion CNY | -15.96% |
| 2006 Q1 | 1.63 Billion CNY | 2.09% |
| 2006 FY | 6.82 Billion CNY | 9.6% |
| 2006 Q4 | 1.75 Billion CNY | -0.55% |
| 2006 Q3 | 1.76 Billion CNY | 5.84% |
| 2006 Q2 | 1.67 Billion CNY | 2.34% |
| 2005 Q4 | 1.59 Billion CNY | -1.89% |
| 2005 Q1 | 1.43 Billion CNY | -7.66% |
| 2005 Q2 | 1.57 Billion CNY | 9.67% |
| 2005 Q3 | 1.62 Billion CNY | 3.76% |
| 2005 FY | 6.22 Billion CNY | 18.44% |
| 2004 Q2 | 1.36 Billion CNY | 19.66% |
| 2004 FY | 5.25 Billion CNY | 24.71% |
| 2004 Q1 | 1.14 Billion CNY | 7.54% |
| 2004 Q3 | 1.2 Billion CNY | -11.86% |
| 2004 Q4 | 1.55 Billion CNY | 28.87% |
| 2003 FY | 4.21 Billion CNY | 103.87% |
| 2003 Q4 | 1.06 Billion CNY | -7.66% |
| 2003 Q1 | 762.18 Million CNY | 33.21% |
| 2003 Q2 | 1.24 Billion CNY | 63.42% |
| 2003 Q3 | 1.14 Billion CNY | -7.77% |
| 2002 Q3 | 538.33 Million CNY | 5.71% |
| 2002 FY | 2.06 Billion CNY | 44.8% |
| 2002 Q1 | 448.93 Million CNY | 0.0% |
| 2002 Q2 | 509.25 Million CNY | 13.44% |
| 2002 Q4 | 572.17 Million CNY | 6.29% |
| 2001 FY | 1.42 Billion CNY | 7.48% |
| 2000 FY | 1.32 Billion CNY | 15.96% |
| 1999 FY | 1.14 Billion CNY | 30.33% |
| 1998 FY | 879.49 Million CNY | 51.03% |
| 1997 FY | 582.33 Million CNY | 15.82% |
| 1996 FY | 502.8 Million CNY | 2.64% |
| 1995 FY | 489.87 Million CNY | 20.65% |
| 1994 FY | 406.03 Million CNY | -10.76% |
| 1993 FY | 454.98 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 22.81 Billion CNY | -134.839% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 10.05 Billion CNY | -432.78% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 6.73 Billion CNY | -695.95% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 2.31 Billion CNY | -2218.02% |
| Aurora Optoelectronics Co.,Ltd. | 327.9 Million CNY | -16242.871% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 121.77 Million CNY | -43905.838% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 1.28 Billion CNY | -4073.599% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 3.07 Billion CNY | -1642.518% |